Market Research Blog – Page 1333 – New Product Development

Powder Dispenser Market Projected to Grow at 5.8% CAGR, Reaching USD 686 Million by 2032 | FMI

The global powder dispenser market is set to experience robust growth, with a projected valuation of USD 686 million by 2032. The market, currently valued at USD 413 million, is expected to register a promising CAGR of 5.8% during the forecast period.

Market Insights and Drivers

Precision and Efficiency: Powder dispensers are known for their ability to dispense precise amounts of powder with ease, making them highly efficient for various applications. Their functionality not only saves time but also ensures accurate dosing, which is essential in many industrial and commercial processes.
Hygienic Benefits: The COVID-19 pandemic has heightened the focus on hygiene and safety, driving increased demand for powder dispensers. These devices help minimize contact and exposure to contaminants by providing a controlled method for powder dispensing. Their ability to create barriers against moisture and gases further enhances their appeal during the pandemic.
Convenience and Durability: Powder dispensers are favored for their convenience in usage and refilling. The machines are designed with aesthetic appeal and durability in mind, making them a preferred choice among end users for their practical benefits and longevity.
Industrial and Commercial Applications: The versatility of powder dispensers makes them valuable across various industries, including pharmaceuticals, food and beverages, and manufacturing. Their role in improving operational efficiency and maintaining product quality contributes to their growing adoption.

Market Growth Across Diverse Sectors

The report highlights the significant role powder dispensers play in various industries:

Pharmaceuticals: Patient-specific dosing requirements in healthcare and pharmaceuticals necessitate accurate powder dispensing, leading to high demand in this sector.
Food & Beverages: Precise measurement of additives and preservatives helps to enhance food quality and shelf life, fueling the demand for powder dispensers in this industry.
Chemicals, Paints & Coatings: Advanced technologies used in these sectors are contributing to the growth of the powder dispenser market.
Other Applications: Cosmetics, textiles, personal care products, and even artistic dispensers used in retail coffee shops are expanding the market’s reach.

Regional Variations and Competitive Landscape

The report also examines the market landscape across different regions:

Asia Pacific: With a booming food and beverage industry, Asia Pacific is experiencing a surge in demand for powder dispensers.
North America: Rising awareness about hygiene and increasing demand for powder-based products like chemicals and fertilizers are expected to propel the market in this region.
Europe: A mature market with established players, Europe is expected to see slower growth compared to other regions.

The report identifies key players in the powder dispenser market, including IDM Ltd, Capsugel, COROB, and Gironex Ltd., who are focusing on:

Durability: Manufacturing robust and long-lasting dispensers.
Advanced Technology: Integrating innovative features for improved efficiency.
Quicker Dispensing: Enhancing dispensing speed for faster production cycles.

Recent Developments:

The report also highlights recent partnerships and advancements within the industry:

COROB’s collaboration with Fine Paints of Europe (FPE) expands the market reach for premium coatings.
Gironex Ltd.’s novel precision dispensing technology improves efficiency in the pharmaceutical sector.

A Promising Future for Powder Dispensers

With increasing automation, hygiene concerns, and demand for precise dosing across various industries, the powder dispenser market is poised for continued growth and development in the coming years.

Regional analysis includes –

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan (APEJ)
Japan
Middle East & Africa (MEA)

Access Full Report: https://www.futuremarketinsights.com/reports/powder-dispenser-market

Key Segments:

By Product Type:

Wall Mounted
Counter Top

By Size:

Below 1 Liter
1 Liter to 5 Liter
6 Liters to 10 Liters
11 Liters to 15 Liters
More than 15 Liters

By Dispensing Mode:

Automatic
Semi-automatic
Manual

By Power Dispensing Capacity:

Pharmaceuticals
Food and Beverages
Automotive
Textiles & Apparel
Household
Healthcare
Cosmetic

By Region:

North America
Latin America
Asia Pacific
Europe
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Egg Carton Market to Reach USD 2.76 Billion by 2034, Driven by Sustainability Trends and Dietary Changes

The global egg carton market is projected to achieve a valuation of USD 2,074.1 million by 2024 and is expected to grow at a steady pace, reaching USD 2,760.5 million by 2034. The market is anticipated to record a CAGR of 2.9% from 2024 to 2034, reflecting consistent growth driven by evolving consumer preferences and sustainability trends.

Key Market Drivers

Rising Egg Consumption and Poultry Industry Expansion: The ongoing increase in egg consumption, driven by dietary trends and the rapid development of the poultry industry, is a primary factor bolstering the egg carton market. With the production of eggs continuing to grow, the need for reliable and protective packaging solutions such as egg cartons remains strong.
Demand for Rigid and Lightweight Packaging: Eggs are fragile products that require sturdy packaging to prevent breakage during transport. Egg cartons made from rigid materials are in high demand to meet this need. At the same time, the packaging industry’s shift toward lightweight solutions further benefits the egg carton market, as these cartons offer both protection and ease of handling.
Convenient Packaging Solutions: The food and beverage industry’s need for convenient and efficient packaging solutions is another factor driving the adoption of egg cartons. These cartons not only protect eggs but also provide a lightweight and easy-to-use packaging option for suppliers.

Market Trends

Adoption of Eggetarian Diets: The growing focus on eggetarian diets, which emphasize the consumption of eggs, is leading to increased demand for egg cartons. As more consumers incorporate eggs into their diets, the market for egg packaging is expected to expand.
Shift Towards Eco-Friendly Materials: As sustainability becomes a central focus in the packaging industry, there is a rising preference for egg cartons made from eco-friendly materials, such as molded fiber and recycled paper. These materials offer a sustainable and cost-effective solution, aligning with consumer and industry trends towards environmentally responsible packaging.
Innovation in Egg Carton Design: Manufacturers are increasingly producing egg cartons with shock and stress-absorbing materials to further ensure the safety of eggs during transport. These innovations in carton design are helping to meet the growing demand for protective packaging.

Industry Growth Drivers:

Increased Consumption of Eggs:
- As the global population continues to grow, there is a parallel increase in the consumption of eggs, driving the demand for egg cartons as a primary packaging solution.
Rising Awareness of Health Benefits:
- Growing awareness of the nutritional benefits of eggs, coupled with increased emphasis on protein-rich diets, fuels the demand for eggs and, consequently, egg cartons.
Shift Towards Sustainable Packaging:
- The global push for sustainability and eco-friendly practices has led to a demand for egg cartons made from recycled or biodegradable materials, contributing to the growth of the market.
Expanding Poultry Farming Industry:
- The continuous expansion of the poultry farming industry, driven by the need to meet the rising demand for eggs, directly impacts the egg carton market, creating a steady demand for packaging solutions.
Retail and Consumer Convenience:
- Convenience in handling and transporting eggs for both retailers and consumers is a significant driver. Egg cartons provide a secure and practical packaging solution, contributing to their widespread adoption in the market.

Egg cartons are characterized by dimpled foams that accommodate individual eggs. This dimpled foam also helps protect eggs by absorbing the stress or shock exerted during transportation. Generally, plastic such as polystyrene form or recycled paper is used for manufacturing egg carton.

The report also focuses on global major leading industry players of Egg Carton Market Share providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.

Market Segmentation:

Based on the material used

Plastic egg cartons
Polystyrene foam
Clear plastic
Paper egg cartons
Recycled paper
Molded pulp

Based on the number of eggs to be stored

3 egg carton
6 egg carton
12 egg carton
24 egg carton

Regional Analysis:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
North America (U.S., Canada, and Mexico)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (Saudi Arabia, UAE, South Africa)

The Egg Carton Market report covers an exhaustive analysis on:

Egg Carton Market Segments
Egg Carton Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The Egg Carton Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The Egg Carton Market report also maps the qualitative impact of various market factors on market segments and geographies.

Access Full Report: https://www.futuremarketinsights.com/reports/egg-carton-market

Egg Carton Market Report Highlights:

Detailed overview of parent market
Changing market dynamics in the Egg Carton industry
In-depth Egg Carton Market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on Egg Carton Market performance
Must-have information for market players to sustain and enhance their market footprint

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Global Medical Rehabilitation Robotics Market Projected to Reach USD 1.76 Billion by 2033 at a 15.2% of CAGR

The global medical rehabilitation robotics market is poised for significant expansion, with forecasts indicating a remarkable compound annual growth rate (CAGR) of 15.2% from 2022 to 2033. The market, valued at USD 366.2 million in 2022, is expected to surge to an impressive USD 1.76 billion by the end of the forecast period.

This robust growth is driven by advancements in robotics technology and an increasing demand for innovative solutions in medical rehabilitation. The integration of robotics in rehabilitation offers enhanced precision, improved patient outcomes, and accelerated recovery times, fueling the market’s expansion.

As the healthcare industry continues to embrace cutting-edge technologies, medical rehabilitation robotics are becoming integral to patient care, contributing to the significant projected growth of this dynamic market.

Along the above-mentioned lines, PARO comes across as a companion robot that has been specially designed for those suffering from Alzheimer’s, dementia, and various other cognition disorders. Dr. Takanori Shibata from Japan’s National Institute of Advanced Industrial Science and Technology has come up with this assistive robot for helping those with disabilities fulfill daily activities like eating and walking.

The robotic lower-body exoskeleton is being used to assist the ones with paralysis of the lower limbs and does encourage muscle activity therein.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Medical Rehabilitation Robotics Market’ with its team of analysts and consultants deploying a 360-degree view in its primary, secondary, and tertiary modes of research.

“With Spike in cases of stroke, the global medical rehabilitation robotics industry is expected to go great guns shortly”, says an analyst from Future Market Insights.

Key Takeaways from the Global Medical Rehabilitation Robotics Industry

North America holds more than 40% of the market share due to growing incidences of spinal cord injury followed by rising aging and disabled population.
Europe holds a significant market share with Germany leading from the front with Spain, Denmark, and the UK leading from the front.
The Asia-Pacific is expected to grow at a rapid pace in the medical rehabilitation robotics industry with countries like Japan obtaining the status of ‘super-aging society’.

Competitive Robotics

Ekso Bionics Holdings, Inc. received approval from the US FDA for marketing the EksoNR robotic exoskeleton for usage with patients suffering from MS (Multiple Sclerosis).
Tyromotion, of late, completed acquisition of yband therapy AG (a Swiss-based start-up) for encouraging patients’ ownership of recovery with cutting-edge movement trackers.
Bionik Laboratories Corporation, in January 2019, did launch InMotion ARM/HAND robotic system to clinically rehabilitate stroke survivors and the ones having mobility impairments owing to neurological conditions. The enhanced robotic system has been developed according to principles of motor learning as well as neuro-plasticity and makes use of AI and data analysis for offering individualized therapy to the patients.
ReWalk Robotics, Inc., in June 2019, did announce that the US FDA approved the ReStore soft exo-suit system for selling to the rehabilitation centers all over the US.
Cyberdyne Inc., in January 2018, obtained approval from the US FDA to sell HAL (Hybrid Assistive Limb) lower-body exoskeleton in the licensed medical facilities all over the US.
Stryker Corporation, in the year 2020, did receive regulatory approval for MAKO robotic surgery system in Japan for partial knee indication.
Accuray, in 2020, did launch CyberKnife S7 System, which comes across as a next-generation CyberKnife platform with real-time, advanced, AI-driven motion tracking as well as synchronization treatment delivery for SBRT (stereotactic body radiation therapy) and SRS (stereotactic radiosurgery).
Medtronic, in 2020, completed acquisition of Medicrea through AI, patient specific implants, and predictive modeling.
Intuitive Surgical, in 2019, did receive clearance from the US FDA regarding da Vinci Single-port Surgical System.

Key Global Medical Rehabilitation Robotics Industry Players:

Ekso Bionics Holdings Inc.
AlterG Inc.
Bionik Laboratories Corp.
Cyberdyne Inc.
Rewalk Robotics.
Instead Technoligies Ltd.
Hocoma AG.
Fourier Intelligene
Tyromotion Gmbh
Toyota Motor Corporation
BeatBots LLC
Bioxtreme
Rex Bionics Inc.
LEADERS REHAB ROBOT Co. Ltd.

A Old Full Report Analysis Click Here

Key Segments Covered in Global Medical Rehabilitation Robotics Industry Research

By Product:

Exoskeletons
Therapeutic/ Assistive

By Extremity:

Upper Extremity
- Arm
- Wrist
- Shoulder
- Elbow
Lower Extremity

By Therapy:

Limb Mobility
Gait
Sensory

By Patient:

Adults
Pediatric

By Application:

Neurorehabilitation
Physical Rehabilitation
Others

By End user:

Hospitals
Wellness centers
Rehabilitation centers
Homecare

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Headspace Gas Analyzers Market Projected to Reach USD 179.88 Million by 2033 at a 8.5% of CAGR

The global headspace gas analyzers market is on a remarkable growth trajectory, with expectations to surpass USD 77.66 million by the end of 2023. This upward trend is projected to continue, with the market forecasted to achieve a substantial compound annual growth rate (CAGR) of 8.5% through 2033, reaching an estimated USD 179.88 million.

The growth of the headspace gas analyzers market is primarily driven by the increasing demand for rapid and non-destructive moisture determination of sterile freeze-dried products. The advanced capabilities of headspace gas analyzers provide a swift, non-destructive alternative to traditional moisture analysis methods, significantly enhancing efficiency in quality control processes.

This technological advancement is streamlining moisture analysis efforts across various industries, contributing to the robust expansion of the market. As the need for precise and efficient moisture analysis continues to rise, the headspace gas analyzers market is poised for continued growth and innovation.

All the drawbacks of destructive inspections are eliminated by headspace gas analyzer techniques, allowing a focused, unbiased evaluation of the entire production process to ensure product stability.

Additionally, they provide sterility throughout the entire life cycle of the product, research and validation, routine manufacturing, and the marketing environment. Because of this, if the rules governing their use are changed, the demand for headspace gas analyzers in the pharmaceutical industry and other industries is likely to increase.

The leading manufacturers of headspace gas analyzers have made technological advancement, new product introductions, and regulatory approvals key growth strategies. By employing these tactics, businesses aim to expand both their regional presence and their product offerings.

For instance, the CCI laboratory tester NEO DPX by WILCO AG received the Good Design Award 2020 in the industrial category in July 2021 from the Chicago Athenaeum Museum of Architecture and Design.

For the visual inspection of parenteralia in various packaging materials, WILCO AG developed a customised system design in six phases in June 2019 to ensure the highest level of reliability for the inspection results.

Such developments strengthen the company’s current portfolio, increase their visibility on a regional and international level, and give them the ability to withstand the increasing competitive pressure.

Key Takeaways from Global Headspace Gas Analyzers Industry Study

By product, oxygen headspace analyzers will hold maximum share of more than 45% in 2021.
In terms of modality, benchtop system of headspace gas analyzers are expected to account for over 60% of the market share in 2021 owing to the extreme stability and accuracy in the inspection of overfilled containers with limited headspace.
By end user, the hospitals will account for over 40% of the market share in 2021 owing to the rising demand for sterile products and increasing percentage of health problems by unhygienic food packaging.
North America is expected to hold nearly 40% of global market share in 2021 on the back of rising product adoption, increasing demand for packaging of pharmaceutical products, health consciousness, and increasing disposable incomes

Who is Winning?

Some of the leading manufacturers of Global Headspace Gas Analyzers Industry are focusing on product launch, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

In June 2021, CS Analytical Laboratory installed LIGHTHOUSE’s Instruments Suite with laser-based headspace capabilities for container closure integrity testing.
In July 2019, Labthink launched a commemorative innovative product, C130H Gas Permeation Test System, a high-precision laboratory testing instrument based on a differential pressure method, to help realize gas permeability, solubility coefficient, and diffusion of thin films and sheets in fields of scientific research, food, pharmaceuticals, packaging materials, and many others, to efficiently enhance product quality control and new product R&D processes.

In July 2017, Illinois Instruments collaborated with OxySense, a leading brand in non-invasive optical oxygen analyzers and permeation testing solutions. OxySense and Systech Illinois had been trusted for decades for delivering the highest quality and most reliable gas measurement solutions.

The key market players covered by FMI include WILCO AG, Quantek Instruments Inc., Illinois Instruments Inc., Labthink International Inc., LIGHTHOUSE, GASPOROX AB, Xepics SA, Bonfiglioli Engineering S.r.l.

A Old Full Report Analysis Click Here

Global Headspace Gas Analyzers Industry by Category

Product:

Oxygen Headspace Analyzers
Carbon Dioxide (CO2) Headspace Analyzers
Combination Headspace Analyzers
Pressure/Moisture Headspace Analyzers

Modality:

Benchtop Systems
Handheld Headspace Analyzer

End User:

Research & Development Facilities
Contract Manufacturing Organizations
Pharmaceuticals Manufacturing
Clinical Trials Agencies

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Pelvic Floor Diagnostics Market Expected to Reach USD 3,753.39 Million by 2033 at a 6.2% of CAGR

The global pelvic floor diagnostics market is projected to achieve a valuation of USD 2,056.74 million in 2023, with substantial growth anticipated over the next decade. By 2033, the market is estimated to expand to USD 3,753.39 million, reflecting a compound annual growth rate (CAGR) of 6.2%.

The report highlights a notable surge in demand for advanced diagnostic technologies, particularly uroflowmetry devices and anal manometry systems. These segments are forecasted to experience a robust CAGR of 8.2% throughout the assessment period, underscoring their increasing importance in the diagnosis and management of pelvic floor disorders.

This growth is driven by the rising prevalence of pelvic floor conditions and a growing emphasis on accurate, non-invasive diagnostic solutions. The advancement of diagnostic technologies and an increased focus on patient-centric care are fueling market expansion and innovation.

Enhancements in reimbursement structures have incentivized manufacturers to invest in the pelvic floor diagnostic sector, thereby creating a favorable environment for sustained growth through the year 2033.

Rising healthcare expenditure, along with growing government support by funding and faster approvals has led to the establishment of pelvic floor diagnostic laboratories and a larger number of professionals.

The rising number of grants by private and government players for pelvic floor diagnostics has increased the focus on innovative research solutions for the development of advanced testing systems.

Healthcare standards with advanced diagnostic procedures have gained ground during the last two decades and with the rise in income and the increased investments in research. The pelvic floor diagnostics market has experienced a substantial shift in the adoption of molecular diagnostic devices.

Key Takeaways from Pelvic Floor Diagnostics Market Study

Ultrasound systems are expected to reach a revenue share of 37.1% in 2021 with a growing CAGR of 5.7% during the forecast period.
Hospitals will drive sales accounting for over 60% of value share through 2031, owing to higher spending capacity.
Mexico will reflect a 6.1% CAGR through 2031, supported by growing access to superior medical facilities.
K. and France are leading markets in Europe, accounting for over 20% and over 18% of the Europe market respectively in 2021.
The U.S. is North America’s largest and fastest-growing market, exhibiting a 5.7% CAGR through the forecast period.

“The growing global geriatric population is prone to pelvic floor disorders. Consequently, advancements in diagnostics including imaging and ultrasound systems, coupled with investments in research and academic bodies are set to boost the growth of the pelvic floor diagnostics market over the coming decade,” says a Future Market Insights analyst.

Investments in Tech Development to Offer Growth Opportunities

The pelvic floor diagnostics market has emerged as a lucrative area of research concerning pelvic dysfunction. The development of imaging technology is gaining traction with the rising demand for high-resolution images.

The demand is fueled by increasing awareness among the growing population about the diagnostic options available. Ultrasound systems offer reliable high-resolution imaging. The evolution in the processes involving detection, diagnosis, and treatment of associated diseases is anticipated to cause a demand surge in the pelvic floor diagnostics market.

Who is winning?

Key players in the pelvic floor diagnostics market are focusing on tapping market potential through strategic mergers and acquisitions. This is driven by efficiency in innovative and specialized product portfolios. The market is also set to expand due to increasing activities in research and development to diagnose pelvic floor disorders.

Some of the leading players in the pelvic floor diagnostics market include but are not limited to Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft, Noraxon USA.

A Old Full Report Analysis Click Here

Segments:

By Product:

Urodynamics Systems
Uroflowmetry Devices
Anal Manometry Systems
Cystoscopes
Ultrasound Systems
- Cart/Trolley Based
- Portable Bladder Ultrasound Systems
EMG

By End User:

Hospitals
Diagnostic Imaging Centers
Specialty Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Wet Wipes Market Set to Nearly Double by 2033, Projected to Reach USD 9.22 Billion at a 7.8% of CAGR

The wet wipes market has generated an impressive USD 4.3 billion in revenue in 2023, with expectations for substantial growth in the coming decade. According to industry forecasts, the market is projected to expand to USD 9.22 billion by 2033, reflecting a compound annual growth rate (CAGR) of 7.8% from 2023 to 2033.

This significant growth is driven by the increasing use of wet wipes for hygiene purposes, especially in regions where access to clean water is limited. The convenience and effectiveness of wet wipes in preventing infections and maintaining cleanliness, coupled with their disposable nature, have led to a surge in consumer demand.

The wet wipes market is benefiting from a broader acceptance of these products across various applications, including personal hygiene, household cleaning, and medical use. As consumers continue to prioritize convenience and hygiene, the market is expected to see continued expansion and innovation.

Market competitors are introducing eco-friendly and biodegradable Wet Wipes produced from wood pulp and cotton as an alternative for synthetic fibres, which is driving wet wipe sales.

The rising prevalence of health-related illnesses in the elderly, such as incontinence-associated dermatitis (IAD) and catheter-associated urinary tract infection (CAUTI), is driving up demand for Wet Wipes, particularly in hospitals.

Wet Wipes are expected to gain traction over the forecast period because they efficiently serve the objective of maintaining hygiene standards and removing germs, dirt, and dust build-up on the skin and other physical surfaces.

In addition, the rise of local and small players, creative product development, clever marketing strategies implemented by top manufacturers, and commercialization of Wet Wipes are increasing the global Wet Wipes market’s growth prospects.

The FMI study projects the US to lead the North America Wet Wipes market. Rapid expansion of distribution channels, coupled with increasing per capita healthcare expenditure are anticipated to bode well for the Wet Wipes market in the U.S.

“Expansion of the ecommerce sector is resulting in easy availability and increasing sales of Wet Wipes across the globe. In addition to this, government-backed healthcare reimbursement plans will continue driving sales of Wet Wipes over the forecast period,” says the FMI analyst.

Key Takeaways:

Incontinence wipes are expected to account for roughly 27% of the worldwide Wet Wipes market share during the forecast period.
The hospital segment is expected to increase at a 6% CAGR through 2031 in terms of end users.
It is estimated that the United States accounts for more than 80% of the North American Wet Wipes market.
Germany will dominate the European Wet Wipes industry in 2021, accounting for 23% of the market.
China is expected to emerge as a profitable market, accounting for 40% of the East Asian Wet Wipes market share.
The Japanese Wet Wipes market is expected to develop at a 9.3% CAGR through 2031, while the South Korean Wet Wipes market is expected to rise at a robust 10% CAGR.

Prominent Drivers:

Collaborations among key market players to launch innovative products will provide tailwinds to Wet Wipes sales during the assessment period.

Restraints:

Availability of cheaper alternatives such as soaps, cleansing milk, and face washes might hamper sales of Wet Wipes.
Chances of allergic reactions and irritability on the skin might result in decreased sales of Wet Wipes.

Competitive Landscape

Leading players operating in the global Wet Wipes market are aiming to expand their global footprint through strategic collaborations, mergers, and acquisitions. In addition to this, launching innovative products, research, and development and strengthening distribution channels will remain key growth strategies among players. For instance:

Medline partnered with Intelligent Observation (IO) in January 2021 to help healthcare professionals manage healthcare-associated infection rates.
Essity announced the acquisition of ABIGO Medical, a wound care company, and Asaleo Care, an Australian hygiene company, in July 2021.

Leading players operating in Wet Wipes Market profiled by FMI include:

Essity Aktiebolag (publ)
Kimberly-Clark
Procter & Gamble
Cardinal Health
Medtronic
Stryker
Coloplast
Others

A Old Full Report Analysis Click Here

More Insights on FMI’s Wet Wipes Market

The latest market study on the Wet Wipes market by Future Market Insights gives a detailed segmentation for the forecast period of 2021 to 2031. In order to gain a better perspective of the global Wet Wipes market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

Product:

Incontinence wipes
- Baby Wipes
- Adult Wipes
Skin Antiseptic Wipes
Feminine Hygiene Wipes
Skin Care Wet Wipes
Sterile Wound Cleansing Wipes

Disposability:

Flushable Wipes
Non-Flushable Wipes

Application:

Incontinence
Skincare
Personal Hygiene
Wound Care

End-User:

Hospitals
Clinics
Specialty Centers
Long term care centers
Homecare Settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Ocular Drug Delivery System Market Projected to Reach USD 31,410.2 Million by 2033 at a 6.9% of CAGR

The ocular drug delivery system market is set to surpass USD 16,159.9 million in 2023, according to a recent report by Future Market Insights. This growth is driven by an increasing prevalence of ophthalmic diseases and a rising emphasis on advanced treatment options, which are fueling demand for innovative ocular drug delivery systems.

The market is forecasted to grow at a robust compound annual growth rate (CAGR) of 6.9% from 2023 to 2033. By the end of this forecast period, the market is expected to reach an impressive USD 31,410.2 million.

A significant factor contributing to this growth is the high demand for particulate drug delivery systems, which are anticipated to dominate the market, accounting for over 70% of global sales in 2023. These systems are favored for their effectiveness in delivering targeted therapies to the ocular region.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as ointments, emulsions, suspensions, aqueous gels, Nano micelles, liposomes, and in situ thermosensitive gels for the earlier mentioned ocular diseases.

Glaucoma is the second-leading cause of blindness worldwide, accounting for up to 8% of total blindness. In India, glaucoma is the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of glaucoma cases remain undiagnosed in the community.

Thus the high incidence of ophthalmic diseases, resulting in the rise significant patient population, is driving the global ocular drug delivery systems market.

The ocular drug has to pass the water-fat-water membranous structure of the cornea and this changing environment presents a significant barrier. That is why, for almost four decades, researchers have been involved in developing intraocular sustained-release drug delivery platforms.

Owing to the rigorous research studies, approvals for new ocular drug delivery techniques are currently recorded globally. This has helped the market to gain momentum over the last few years.

Key Takeaways from Global Ocular Drug Delivery System Industry Study

Increasing focus on pharmaceutical innovation and research on drug delivery technologies is driving a transition towards particulate drug delivery systems, which will account for over 68% of the market in 2021.
Ophthalmic solution for ocular drug delivery systems is expected to account for 60% of the global market share by 2031.
Among distribution channels, hospital pharmacies accounted for 40% of the market share in 2031. The soaring influx of patients for treatment and the availability of intensive care support has propelled the demand in the segment.
North America holds the maximum share, owing to the presence of Tier 1 players, high per-capita healthcare expenditure, and favorable reimbursement policies in the region.
The U.S. holds a more than 44% share in the global ocular drug delivery systems market.
The U.K. and Germany are leading markets in Europe, accounting for more than 41% of the Europe market in 2021.
South Korea is the fastest-growing market in East Asia, exhibiting a 10.3% CAGR through 2031.

“Increasing prevalence of eye infections, innovation in drug delivery technologies, and rising clinical trials are creating lucrative growth opportunities for ocular drug delivery system sales,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Increase in Funding for Research Activities Offers Growth Opportunities

Leading manufacturers in the Global Ocular Drug Delivery System Industry are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research of pharmaceutical products.

For instance, In April 2017, Santen Pharmaceuticals announced a strategic investment in Regenerative Patch Technologies LLC, a U.S.-based company engaged in the development of ophthalmic therapies.

Pharmaceutical giants are expected to benefit from the globalization of labor forces, that is, the employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Who is Winning?

The global market is set to expand due to the rising prevalence of eye infections. Leading players within this space are expected to focus on research and development to offer an early and precise diagnosis of ailment, besides offering effective patient care.

Some of the leading players in the Global Ocular Drug Delivery System Industry include but are not limited to Allergan Plc., Graybug Vision Inc., Ocular Therapeutix, Inc., Alimera Sciences, pSivida, Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company Ltd., Envisia Therapeutics, Eyegate Pharma, Valeant Pharmaceuticals International, Inc, Vision Ophthalmology Group GmbH, Clearside Biomedical, URSAPHARM Arzneimittel GmbH.

Want More Insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global ocular drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the ocular drug delivery systems treatment based on the key indication in detail, covering every aspect of the market such as technology, dosage form, and distribution channel across seven major regions.

A Old Full Report Analysis Click Here

Ocular Drug Delivery Systems Market by Category

By Technology:

Implantable
Particulate
Nanoparticle

By Dosage Form:

Ophthalmic Solution
Ophthalmic Suspension
Ophthalmic Emulsion
Ophthalmic Gels
Ophthalmic Ointments

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Store
Mail Order Pharmacies

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Femtech Market Projected to Grow to USD 43,406.1 Million by 2034 at a 4.5% of CAGR

The global femtech market is on track to achieve a valuation of USD 27,956.4 million in 2024, reflecting continued robust growth from its estimated USD 26,818.2 million in 2023. The market is anticipated to maintain an average growth rate over the next decade, with a compound annual growth rate (CAGR) of 4.5% projected from 2024 to 2034.

By 2034, the femtech market is expected to expand significantly, reaching an estimated USD 43,406.1 million. This growth underscores the increasing investment and innovation in technologies and solutions that address women’s health and wellness issues.

The steady expansion of the femtech sector highlights the rising demand for specialized healthcare products and services tailored to women’s unique needs. As the industry evolves, continued advancements and increased focus on women’s health are anticipated to drive market growth.

Femtech, a rapidly emerging segment of the healthcare industry, offers a range of digital health tools and solutions designed to precisely address the unique healthcare needs of women. From menstrual health management and menopause support to reproductive health and conception tracking, femitech advancements are giving women the power to take control of their health and wellbeing.

Emergence of Femtech Solutions and Technology

This subsegment of the femtech market includes devices, software, and services. The demand for improved diagnostic and treatment choices will expand as infectious and chronic diseases become more common among women, propelling the segment’s growth.

Companies are constantly focusing on developing innovative, cutting-edge techniques to improve women’s health and wellness. The market will expand with improvements made, among other things, to women’s health products.

The primary barriers to the femtech market are described as demography, population fluctuations, and the gap between urban and rural locations. The goal of societal expectations on women’s health, specifically with regard to menstruation, fertility, sexual health, and birth control, is to limit the growth of the market.

Women users’ ignorance of available products and applications may be a barrier to the growth of the femtech industry in developing countries. A fiercely competitive industry is emerging as a result of the growing number of femtech companies, including start-ups.

Because of the increasing number of patients in nations like China and India, the Asia Pacific area is expected to hold one of the largest femtech market shares. Femtech solutions are becoming more and more accepted in the US as a result of growing awareness of women’s health issues, particularly those related to menstruation and fertility.

The main players are focused on providing customized prenatal care, among other services. Femtech services are being used more widely in the nation as a result of these causes. Femtech is gaining traction as seen by the rising incidence of menstrual problems, which is increasing customer acceptability of direct-to-consumer marketing.

Key Takeaways:

In the femtech market Diagnostics in the service segment are to grow at a CAGR of 13.2% through 2033.
Menstrual Health is expected to accelerate at a CAGR of 12.4% in the femtech market through 2033.
During the projection period, the U.S. market for femtech is expected to grow at a CAGR of 12.2% and reach US$ 1.4 Billion by 2033.
Femtech sales in the United Kingdom are expected to grow at a CAGR of 14.3% over the forecasted period and hit US$ 274.6 Million by 2033.
By 2033, the China femtech market is set to reach US$ 438.9 Million, registering a CAGR of 17.1%.
Femtech sales in Japan are likely to increase by a CAGR of 18% over the forecasted period and achieve US$ 368.1 Million by 2033.
During the forthcoming years, the market for femtech in South Korea is assumed to expand at a CAGR of 19.9% and attain US$ 107.7 Million by 2033.

Competitive Landscape :

Some of the market leaders in femtech include Flo Health, Inc., Apple, Inc., Clue by Biowink GmbH, Glow, Inc., Google, Inc., Natural Cycles USA Corp., Withings, and Fitbit, Inc. Market players throughout the world are being compelled to provide novel product offerings and technical solutions as a result of the increased demands brought on by the unmet healthcare needs of the female population.

To increase their commercial reach, key participants are concentrating on mergers and acquisitions and technology partnership methods.

A Old Full Report Analysis Click Here

Key Segments :

By Service:

Diagnostics
Monitoring
Therapeutic

By Application:

General Health and Wellness
Maternity Care
Menstrual Health
Pelvic and Uterine Healthcare
Cancer and Chronic Disease

By End User:

Direct-to-consumer
Hospitals
Surgical Centers
Fertility Clinics
Diagnostics Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Urinary Bag Market Set to Exceed USD 1,899.3 Million by 2023, Forecasted to Surge to USD 2,911.7 Million by 2033 at a 4.4% of CAGR

The global urinary bag market is on a strong upward trajectory, with projections indicating it will surpass USD 1,899.3 million by the end of 2023. This remarkable growth is set to continue at a compound annual growth rate (CAGR) of 4.4%, pushing the market to an estimated USD 2,911.7 million by 2033.

The market’s expansion is driven by a significant increase in the prevalence of urinary incontinence and urinary retention disorders. As the global population ages and healthcare needs evolve, the demand for effective urinary management solutions has surged.

In addition to this growing demand, there is a heightened focus on sustainability within the urinary bag sector. Manufacturers are responding to environmental concerns by investing in eco-friendly materials and implementing recycling initiatives. These efforts are aligned with a broader trend towards reducing waste and developing sustainable product solutions in the healthcare industry.

The combination of increased prevalence of urinary disorders and a push for environmentally responsible practices is shaping the future of the urinary bag market, promising both growth and innovation in the years ahead.

The emergence of smart and digital solutions has transformed the market. Innovative technologies such as wireless monitoring systems, smart sensors, and mobile applications have been integrated into Urinary Bags. Further, these technologies enable real-time monitoring of urine volume, temperature, and flow rates.

Digital solutions not only enhance patient monitoring but also facilitate remote patient management, reducing the need for frequent hospital visits and improving the efficiency of healthcare delivery.

Access to Urinary Bags can be a challenge, particularly in low-resource settings and developing countries. The availability and affordability of high-quality Urinary Bags may be limited. It may lead to inadequate management of urinary incontinence for patients who cannot afford or access appropriate products. Addressing this challenge requires a focus on affordability, distribution networks, and increasing awareness about the importance of proper urinary care.

Top Highlights from FMI’s Analysis:

In 2022, North America held a value share of 34.5% in the Urinary Bag industry.
The market in Europe accounted for a value share of 28.6% in 2022 on a global level.
By product type, drainage bags held a substantial value share of 52.24% in 2022.
The market value for Urinary Bags reached US$ 1821.0 billion in 2022, with a CAGR of 4.1% from 2018 to 2022.
Based on end-use, the hospitals sub-segment was predicted to account for a 40.2% share in 2022.
The market for Urinary Bags in India is likely to secure a 6.9% CAGR from 2023 to 2033.

How Fierce Is the Competition in the Urinary Bag Market?

The market consists of both established players with a strong market presence and new entrants striving to gain a foothold. Established companies have a competitive advantage due to their brand reputation, extensive distribution networks, and customer loyalty. Moreover, they often have the resources to invest in research and development, marketing, and strategic partnerships.

Companies in the Urinary Bag market engage in strategic partnerships, collaborations, and acquisitions to strengthen their market position and expand their capabilities. These alliances help in leveraging complementary strengths, accessing new markets, and sharing resources, leading to increased competitiveness in the market.

Ongoing investment in research and development allows companies to develop innovative products, improve existing offerings, and stay ahead of competitors. Companies that invest in research and continuously bring new and improved products to the market have a competitive edge.

Expanding into new geographic regions or targeting niche segments provides opportunities for growth and increased competitiveness. Companies that successfully enter new markets or address specific customer needs, gain an advantage over competitors.

Compliance with regulatory standards and certifications is crucial in the medical device industry, including the market. Manufacturers that meet or exceed regulatory requirements demonstrate their commitment to quality and patient safety, enhancing their competitive position.

Urinary Bag Market Major Players:

Medline Industries, Inc.
Cardinal Health, Inc.
Hollister Incorporated
Teleflex Incorporated
Cook Medical
Moore Medical LLC
Mckesson Medical-Surgical Inc.
Arcus Medical LLc
Urocare
Covidien
Coloplast A/S
Others

A Old Full Report Analysis Click Here

Urinary Bag Market Key Segmentation are:

By Product Type:

Drainage Bags
Leg Bags
Large Capacity Bags
Belly Bags

By Capacity:

Less than 500 ml
500 ml
1000 ml
2000 ml
4000 ml

By Usage:

Reusable Urinary Bags
Disposable Urinary Bags

By Patient Age:

Pediatric
Adult

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Long-Term Care Centers
Home Care

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ophthalmic Eye Drop Market Set for Significant Growth, USD 25,876.4 Million by 2034 at a 4.7% of CAGR

The global ophthalmic eye drop market is on track for notable expansion, with an anticipated increase from USD 17,271.8 million in 2024 to approximately USD 25,876.4 million by 2034. The market is projected to experience a compound annual growth rate (CAGR) of 4.7% over the forecast period.

In 2023, the ophthalmic eye drop market was valued at USD 16,390.6 million and is expected to show a year-over-year growth of 5.4% in 2024. This growth is driven by increasing prevalence of eye conditions, rising awareness of eye health, and advancements in ophthalmic treatments.

The expansion of the ophthalmic eye drop market reflects a broader trend towards enhanced treatment options and greater access to eye care solutions. Innovations in formulations and delivery mechanisms are contributing to market growth, as well as an increasing focus on personalized medicine and patient-centric care.

New eye drop product launches, branded as well as generic, are expected to be hampered in the short term due to disruptions in the supply chain, delayed pipeline research and development, and a shift in the priority of leading healthcare companies to COVID-19 vaccine and treatment developments.

According to the report, institutional sales of ophthalmic eye drops will rise considerably in the coming years. It will account for over half of ophthalmic eye drops sold through the forecast period.

“Increasing prevalence of eye infections, technological advancements, and high risk of infections from the increasing use of contact lens is expected to boost the growth of the Global Ophthalmic Eye Drops Industry.” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Key Takeaways from Global Ophthalmic Eye Drops Industry Study

Ophthalmic eye drops market will expand consistently to surpass a valuation of US$ 15 Bn by 2021
The U.S. holds over 92.1% share of the North American market, but Canada is projected to expand faster at around 4.0% CAGR
Rising cases of eye infection will drive sales in the U.K., enabling it to register 3.9% y-o-y growth in 2021
Rising willingness to spend on advanced eye care will drive sales in Germany and France
Expansion of the healthcare sector will emerge as the chief growth driver in China and Japan. Both countries will exhibit a high demand for dilation drops

Due to their increasingly active lifestyle and desire for better aesthetics, many people are shifting to contact lenses. However, many ocular infections are associated with the use of contact lenses. Each year in the United States, approximately 1 million eye infections occur related primarily to keratitis, a fungal infection of the cornea, and contact lens infections account for estimated direct costs of $175 million. In addition, 40.9 million U.S. adults wear contact lenses, and 99% of 4,269 contact lens wearers reported at least one contact lens–related hygiene behavior associated with an increased risk for eye infection or inflammation. Nearly a million eye infections requiring a trip to the doctor happen each year, many of them related to contact lens use.

Who is Winning?

The top players are focusing on increasing acquisitions at the regional level. Acquisitions empower the company with products and increase the company’s portfolio. The company acquires other players to possess well-established products and solutions that are expected to become a good revenue source for the acquirer. Acquisitions also enable the company to enter new emerging markets as well as enhance its presence in existing markets. Furthermore, key market players such as Novartis and Gerresheimer AG are focusing on the expansion of their market reach in different regions. For example-

In November 2020, Gerresheimer Regensburg announced that it was expanding its production area in Germany. The company has planned the expansion of its production capacity in small batch production, as a result of increasing development projects for pharmaceutical and medical technology products.
In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, strengthening its position in the world’s third-largest generics market.

Some of the key market players covered by FMI include Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., and Amcor Plc.

A Old Full Report Analysis Click Here

Global Ophthalmic Eye Drops Industry by CategoryDrug Class

Anesthetic Drops
Dilation Drops
Glaucoma Drops
Steroid Drops
Antibiotic Drops
Others (Antihistamines, Lubricants Tear Drops)

Indication

Dry Eye
Eye Allergy
Glaucoma
Eye Infection
Retinal Disorders
- Macular Degeneration
- Diabetic Retinopathy
- Others
Uveitis
Others

Drug Formulation

With Preservative
Preservative Free

Container Type

Single Dose Container
Multiple-Dose Container

Distribution Channel

Institutional Sales
- Hospitals
- Community Clinics
- Ophthalmic Clinics
- Public Health Agencies
- Veterinary Hospitals & Clinics
Retail Sales
- Retail Pharmacies
- Drug Stores

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: